Cellectis S.A. (EPA:ALCLS)
2.698
-0.252 (-8.54%)
Jun 3, 2026, 5:35 PM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €195.88 million as of June 3, 2026. Its market cap has increased by 94.10% in one year.
Market Cap
195.88M
Enterprise Value
106.47M
Revenue
65.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.70
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 195.88M, an increase of 94.72%. That is a compound annual growth rate of 3.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 195.88M | -35.44% |
| Dec 31, 2025 | 303.40M | 158.68% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 869.26M |
| Valneva SE | 475.44M |
| Genfit | 426.75M |
| Transgene | 223.49M |
| Sensorion | 222.10M |
| Innate Pharma | 148.63M |
| ABIONYX Pharma | 98.82M |
| Valerio Therapeutics Société anonyme | 95.79M |